Tzu-hao H. Li

Chiayi Branch
Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Hierarchical analysis of metabolic phenotype reveals distinct microbiota and circulatory transcriptome in metabolic dysfunction-associated steatotic liver disease.

Hierarchical analysis of metabolic phenotype reveals distinct microbiota and circulatory transcriptome in metabolic dysfunction-associated steatotic liver disease.

Journal: Gene

Published: March 21, 2026

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation.

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation.

Journal: Frontiers in endocrinology

Published: February 01, 2026

Efficacy of CPAP Therapy on Liver Steatosis and Insulin Resistance in Fatty Liver Patients With Obstructive Sleep Apnea: A 4-Year Follow-Up Cohort Study.

Efficacy of CPAP Therapy on Liver Steatosis and Insulin Resistance in Fatty Liver Patients With Obstructive Sleep Apnea: A 4-Year Follow-Up Cohort Study.

Journal: The Kaohsiung journal of medical sciences

Published: December 29, 2025

Adenosine A2AR agonist blocks mesenteric lymphatic epithelium, adipose tissue and Treg cells links of metabolic dysfunction-associated steatotic liver disease mice.

Adenosine A2AR agonist blocks mesenteric lymphatic epithelium, adipose tissue and Treg cells links of metabolic dysfunction-associated steatotic liver disease mice.

Journal: Molecular and cellular endocrinology

Published: June 20, 2025

Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Microbial Consortia-Immunoglobulin G Glycosylation Combination Scores Identify Severe Hepatic Steatosis and Significant Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Clinical and translational gastroenterology

Published: April 09, 2025

Increased risk of acute exacerbation in obstructive airway disease: the impact of metabolic dysfunction-associated steatotic liver disease and small airway dysfunction.

Increased risk of acute exacerbation in obstructive airway disease: the impact of metabolic dysfunction-associated steatotic liver disease and small airway dysfunction.

Journal: BMJ open respiratory research

Published: March 30, 2025

Triglyceride-glucose index and cancer risk: a prospective cohort study in Taiwan.

Triglyceride-glucose index and cancer risk: a prospective cohort study in Taiwan.

Journal: Diabetology & metabolic syndrome

Published: March 01, 2025

Protective effects of statins on pulmonary function in patients with persistent hyperlipidemia: a retrospective cohort study.

Protective effects of statins on pulmonary function in patients with persistent hyperlipidemia: a retrospective cohort study.

Journal: Therapeutic advances in respiratory disease

Published: February 24, 2025

Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study.

Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study.

Journal: Journal of autoimmunity

Published: February 13, 2025

GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia.

GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia.

Journal: The Kaohsiung journal of medical sciences

Published: November 25, 2024

Peroxisome Proliferator-Activated Receptor α/γ and Cannabinoid Receptor 2 Agonist Attenuated Nonalcoholic Steatohepatitis Exosome-Related Abnormalities in Mice.

Peroxisome Proliferator-Activated Receptor α/γ and Cannabinoid Receptor 2 Agonist Attenuated Nonalcoholic Steatohepatitis Exosome-Related Abnormalities in Mice.

Journal: The American journal of pathology

Published: June 20, 2024

Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures.

Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures.

Journal: Endocrine connections

Published: March 02, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026